{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"glutaric-acidemia-type-3","columns":[{"gene":"","key":"population-7546c81bb86b61ceb4aa","label":"Glutaric aciduria III","mondoId":"MONDO:0009283","onsetQualifier":null,"originColumnKey":"MONDO:0009283/OMIM:231690","originalViews":[{"key":"MONDO:0009283/OMIM:231690","label":"Glutaric aciduria III","scopeLabel":"OMIM:231690","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["0d4ca23584826343f1b8dac06af619a1a0b76e19baabed276722d82e3f7042e5","3820851f57bbc97d052c9415cca7cf22f276bc7cd53b0a463386c1c34494c10b","5248cd395ebbd5d339d51b1a682c1e29dbcfb43d031cce03874a41976ab14dc9","67733383904cbc2ead9d5dc5fdc42cd3f164bf6a3080a807b6cd213d113082c5","910b0c9d729833e42cb17634c7e1d1f0cb81a37e5e58f69b041c83108e2c720c","a043fa71ca66f565b998d9bee40367348ce2204f2c2d9e830360b30ee55f19b4","a30f89ae32c2135c02b1f19771eeaacd5433ae74021d51ec10d821edf60e70a3","c6aaae3f1d3af67d4f501dd21bf964ee66dbc22ed4949975200631d1310666fb"],"recordQualifiers":{},"scopeLabel":"OMIM:231690","sourceIds":["OMIM:231690"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."},{"gene":"","key":"population-2c5ea293b9ea8f065b90","label":"Glutaric acidemia type 3","mondoId":"MONDO:0009283","onsetQualifier":null,"originColumnKey":"MONDO:0009283/ORPHA:35706","originalViews":[{"key":"MONDO:0009283/ORPHA:35706","label":"Glutaric acidemia type 3","scopeLabel":"ORPHA:35706","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["09dad744a510267a982d1d5e7bafb88a2be07ac758eb908f36207d429d3bf97e","1eec73c56052726f883768f51bcbd86e3dc94efab4d1c109ebd18c07480cff70","33b209f45b263aabcc9dce3999b5e9af2c4bb3a22b16ed6023563c6adf9ed0cc","353ace60c0b7b0268e48eb6bb819df9ac9e34f577a176169212fb132d6c5f964","6c7df695b45e517d48eac9de13a796b3f271f07d094c1d60fda86dabce7db09e","72d06c9195c77b66c4b21eba2985c32c00a07a80dbfca587c6bade10ff3e3056","75f1d1814d2b8e4eccfc84d5e4d697af05427ba5c627ead3dd7fbb206c8cebd9","850b1c7ae3a0b51452668d5b6d6398ac9a4bc4d1c7a01b856c904e93bcf728e6","8e97f0ae6222604b1e511126b2a7daffa3ba395148d6355d601325c2dd0bac95","900fc690c4fc7c9c0019f46b4f5b774878c64a51b8aa6b9ab602098af5ce9df9","9a6fc2b51e7bdfc3086f2a5b00daf2683c3205c1ea2c4ac6c25ed6d6bfca2cc3","afb00d463bc997e90e786c6c68c3d0fbb7b90f3c28bd4cbbc90c790840b79072","c48aa9e448592cdfbbd9d51be04b899dd899ccdb233c581b060cee11c58755af"],"recordQualifiers":{},"scopeLabel":"ORPHA:35706","sourceIds":["ORPHA:35706"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-7546c81bb86b61ceb4aa","population-2c5ea293b9ea8f065b90"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0002500","HP:0011021","HP:0002518","HP:0002014","HP:0003530","HP:0001508","HP:0001263"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":1,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":21,"sourceGroups":{"omim":6,"orphanet":13,"published":2}},"features":[{"hpoId":"HP:0002500","label":"Abnormal cerebral white matter morphology","primary":true},{"hpoId":"HP:0011021","label":"Abnormal circulating enzyme concentration","primary":true},{"hpoId":"HP:0002518","label":"Abnormal periventricular white matter morphology","primary":true},{"hpoId":"HP:0002014","label":"Diarrhea","primary":true},{"hpoId":"HP:0003530","label":"Elevated circulating glutaric acid concentration","primary":true},{"hpoId":"HP:0001508","label":"Failure to thrive","primary":true},{"hpoId":"HP:0001263","label":"Global developmental delay","primary":true},{"hpoId":"HP:0003150","label":"Glutaric aciduria","primary":false},{"hpoId":"HP:0000853","label":"Goiter","primary":false},{"hpoId":"HP:0000822","label":"Hypertension","primary":false},{"hpoId":"HP:0000836","label":"Hyperthyroidism","primary":false},{"hpoId":"HP:0100710","label":"Impulsivity","primary":false},{"hpoId":"HP:0001993","label":"Ketoacidosis","primary":false},{"hpoId":"HP:0002919","label":"Ketonuria","primary":false},{"hpoId":"HP:0001254","label":"Lethargy","primary":false},{"hpoId":"HP:0034688","label":"Reduced peroxisomal glutaryl-CoA oxidase activity","primary":false},{"hpoId":"HP:0000960","label":"Sacral dimple","primary":false},{"hpoId":"HP:0001328","label":"Specific learning disability","primary":false},{"hpoId":"HP:0002013","label":"Vomiting","primary":false}],"ledeHtml":"Glutaric acidemia type III is a rare metabolic condition characterized by persistent, isolated accumulation or excretion of glutaric acid. No specific phenotype has been described, as symptoms vary and some individuals remain symptom-free. Unlike other types of glutaric acidemia, this type is caused by a peroxisomal rather than a mitochondrial dysfunction. Genetic changes in the C7ORF10 gene on chromosome 7p14 have been identified in some people with Glutaric acidemia type III and the condition follows an autosomal recessive pattern of inheritance.","mondoId":"MONDO:0009283","node":{"canonicalSlug":"glutaric-acidemia-type-3","comparisons":[{"documentSha256":"29be8cb597581d984004ee288bdb75ec94c84ac9138e17dc94667dff00d610c1","key":"legacy-glutaric-acidemia-type-3","kind":"legacy","label":"glutaric acidemia type 3","memberIds":["MONDO:0009283"],"mondoId":"MONDO:0009283","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/glutaric-acidemia-type-3.29be8cb597581d984004ee288bdb75ec94c84ac9138e17dc94667dff00d610c1.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Glutaryl-CoA oxidase deficiency","originalSourceId":"ORPHA:35706","paragraphs":["Glutaric acidemia type III is a rare metabolic condition characterized by persistent, isolated accumulation or excretion of glutaric acid. No specific phenotype has been described, as symptoms vary and some individuals remain symptom-free. Unlike other types of glutaric acidemia, this type is caused by a peroxisomal rather than a mitochondrial dysfunction. Genetic changes in the C7ORF10 gene on chromosome 7p14 have been identified in some people with Glutaric acidemia type III and the condition follows an autosomal recessive pattern of inheritance."],"rawAttribution":"MONDO:0009283","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T16:59:52Z","upstream":"GARD:0012469","url":"https://rarediseases.info.nih.gov/diseases/12469"},"ownColumnKeys":["population-7546c81bb86b61ceb4aa","population-2c5ea293b9ea8f065b90"],"publication":"published","relationships":[{"kind":"parent","label":"glutaric aciduria","mondoId":"MONDO:0000129","slug":null},{"kind":"parent","label":"inborn organic aciduria","mondoId":"MONDO:0000688","slug":"inborn-organic-aciduria"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"range","key":"09dad744a510267a982d1d5e7bafb88a2be07ac758eb908f36207d429d3bf97e","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:35706","disease_name":"Glutaric acidemia type 3","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001254","is_excluded":false,"label":"Lethargy","onset_id":null,"reference":"ORPHA:35706","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"0d4ca23584826343f1b8dac06af619a1a0b76e19baabed276722d82e3f7042e5","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:231690","disease_name":"Glutaric aciduria III","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0034688","is_excluded":false,"label":"Reduced peroxisomal glutaryl-CoA oxidase activity","onset_id":null,"reference":"PMID:1909402","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"1eec73c56052726f883768f51bcbd86e3dc94efab4d1c109ebd18c07480cff70","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:35706","disease_name":"Glutaric acidemia type 3","evidence":"TAS","frequency_raw":"HP:0040280","hpo_id":"HP:0003150","is_excluded":false,"label":"Glutaric aciduria","onset_id":null,"reference":"ORPHA:35706","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"33b209f45b263aabcc9dce3999b5e9af2c4bb3a22b16ed6023563c6adf9ed0cc","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:35706","disease_name":"Glutaric acidemia type 3","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000960","is_excluded":false,"label":"Sacral dimple","onset_id":null,"reference":"ORPHA:35706","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"353ace60c0b7b0268e48eb6bb819df9ac9e34f577a176169212fb132d6c5f964","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:35706","disease_name":"Glutaric acidemia type 3","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002500","is_excluded":false,"label":"Abnormal cerebral white matter morphology","onset_id":null,"reference":"ORPHA:35706","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3820851f57bbc97d052c9415cca7cf22f276bc7cd53b0a463386c1c34494c10b","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:231690","disease_name":"Glutaric aciduria III","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000836","is_excluded":false,"label":"Hyperthyroidism","onset_id":null,"reference":"OMIM:231690","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"5248cd395ebbd5d339d51b1a682c1e29dbcfb43d031cce03874a41976ab14dc9","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:231690","disease_name":"Glutaric aciduria III","evidence":"PCS","frequency_raw":"6/6","hpo_id":"HP:0003150","is_excluded":false,"label":"Glutaric aciduria","onset_id":null,"reference":"PMID:18926513","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"67733383904cbc2ead9d5dc5fdc42cd3f164bf6a3080a807b6cd213d113082c5","raw":{"aspect":"P","body_system":"growth","disease_id":"OMIM:231690","disease_name":"Glutaric aciduria III","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001508","is_excluded":false,"label":"Failure to thrive","onset_id":null,"reference":"OMIM:231690","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"6c7df695b45e517d48eac9de13a796b3f271f07d094c1d60fda86dabce7db09e","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:35706","disease_name":"Glutaric acidemia type 3","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002919","is_excluded":false,"label":"Ketonuria","onset_id":null,"reference":"ORPHA:35706","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"72d06c9195c77b66c4b21eba2985c32c00a07a80dbfca587c6bade10ff3e3056","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:35706","disease_name":"Glutaric acidemia type 3","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001508","is_excluded":false,"label":"Failure to thrive","onset_id":null,"reference":"ORPHA:35706","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"75f1d1814d2b8e4eccfc84d5e4d697af05427ba5c627ead3dd7fbb206c8cebd9","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:35706","disease_name":"Glutaric acidemia type 3","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001993","is_excluded":false,"label":"Ketoacidosis","onset_id":null,"reference":"ORPHA:35706","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"850b1c7ae3a0b51452668d5b6d6398ac9a4bc4d1c7a01b856c904e93bcf728e6","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:35706","disease_name":"Glutaric acidemia type 3","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0100710","is_excluded":false,"label":"Impulsivity","onset_id":null,"reference":"ORPHA:35706","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8e97f0ae6222604b1e511126b2a7daffa3ba395148d6355d601325c2dd0bac95","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:35706","disease_name":"Glutaric acidemia type 3","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0011021","is_excluded":false,"label":"Abnormal circulating enzyme concentration","onset_id":null,"reference":"ORPHA:35706","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"900fc690c4fc7c9c0019f46b4f5b774878c64a51b8aa6b9ab602098af5ce9df9","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:35706","disease_name":"Glutaric acidemia type 3","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001328","is_excluded":false,"label":"Specific learning disability","onset_id":null,"reference":"ORPHA:35706","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"910b0c9d729833e42cb17634c7e1d1f0cb81a37e5e58f69b041c83108e2c720c","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:231690","disease_name":"Glutaric aciduria III","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000822","is_excluded":false,"label":"Hypertension","onset_id":null,"reference":"OMIM:231690","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"9a6fc2b51e7bdfc3086f2a5b00daf2683c3205c1ea2c4ac6c25ed6d6bfca2cc3","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:35706","disease_name":"Glutaric acidemia type 3","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003530","is_excluded":false,"label":"Elevated circulating glutaric acid concentration","onset_id":null,"reference":"ORPHA:35706","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"a043fa71ca66f565b998d9bee40367348ce2204f2c2d9e830360b30ee55f19b4","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:231690","disease_name":"Glutaric aciduria III","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002014","is_excluded":false,"label":"Diarrhea","onset_id":null,"reference":"OMIM:231690","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"a30f89ae32c2135c02b1f19771eeaacd5433ae74021d51ec10d821edf60e70a3","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:231690","disease_name":"Glutaric aciduria III","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000853","is_excluded":false,"label":"Goiter","onset_id":null,"reference":"OMIM:231690","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"afb00d463bc997e90e786c6c68c3d0fbb7b90f3c28bd4cbbc90c790840b79072","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:35706","disease_name":"Glutaric acidemia type 3","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002518","is_excluded":false,"label":"Abnormal periventricular white matter morphology","onset_id":null,"reference":"ORPHA:35706","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c48aa9e448592cdfbbd9d51be04b899dd899ccdb233c581b060cee11c58755af","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:35706","disease_name":"Glutaric acidemia type 3","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001263","is_excluded":false,"label":"Global developmental delay","onset_id":null,"reference":"ORPHA:35706","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"c6aaae3f1d3af67d4f501dd21bf964ee66dbc22ed4949975200631d1310666fb","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:231690","disease_name":"Glutaric aciduria III","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002013","is_excluded":false,"label":"Vomiting","onset_id":null,"reference":"OMIM:231690","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/12469\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0009283\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>GARD:0012469</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Glutaric acidemia type III is a rare metabolic condition characterized by persistent, isolated accumulation or excretion of glutaric acid. No specific phenotype has been described, as symptoms vary and some individuals remain symptom-free. Unlike other types of glutaric acidemia, this type is caused by a peroxisomal rather than a mitochondrial dysfunction. Genetic changes in the C7ORF10 gene on chromosome 7p14 have been identified in some people with Glutaric acidemia type III and the condition follows an autosomal recessive pattern of inheritance.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/12469\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"glutaric-acidemia-type-3","sourceDocuments":[{"name":"GARD: Glutaryl-CoA oxidase deficiency","reviewed":null,"source_release":"2026-10-21T16:59:52Z","url":"https://rarediseases.info.nih.gov/diseases/12469"},{"name":"MONDO: glutaric acidemia type 3","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0009283"}],"sourceNote":"","synonyms":["GA III","GA3","glutaric acidemia type 3","glutaric acidemia type III","glutaric aciduria (disease) caused by mutation in SUGCT","glutaric aciduria type 3","glutaric aciduria type III","glutaryl-CoA oxidase deficiency","SUGCT glutaric aciduria (disease)"],"takeawayHtml":"","title":"glutaric acidemia type 3"},"schemaVersion":1}
